MADRID, November 11 (HSMN NewsFeed) — Cellerix, a product-focused biopharmaceutical company which develops innovative medicines based on cell therapy, today announced the successful first closing of its financing round, raising EUR27 million. Participan…
Regenerative Medicine, Biopharmaceuticals, Venture Capital
Cellerix, Ontaril

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Cellerix Raises EUR27 Million in a First Closing”
Leave a Comment